This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Immune Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Key information
n/a
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | n/a |
| Equity | n/a |
| Total liabilities | n/a |
| Total assets | n/a |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if IMNP.Q's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if IMNP.Q's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: IMNP.Q is debt free.
Reducing Debt: IMNP.Q has no debt compared to 5 years ago when its debt to equity ratio was 62.4%.
Debt Coverage: IMNP.Q has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: IMNP.Q has no debt, therefore coverage of interest payments is not a concern.